|
|
||||||||



Départements de
*
Maladies Infectieuses and
Génétique Développement et Pathologies Moléculaires, Institut Cochin, Institut National de la Santé et de la Recherche Médicale U567, Centre National de la Recherche Scientifique UMR8104, Université Paris 5, Paris, France;
Laboratoire de Physiologie Cellulaire, Institut National de la Santé et de la Recherche Médicale EMI0228, Université Lille 1, Villeneuve dAscq, France; and
Institut National de la Santé et de la Recherche Médicale U526, Faculté de Médecine Pasteur, Nice, France
Siva-1 is a death domain-containing proapoptotic protein identified as an intracellular ligand of CD27 and of the glucocorticoid-induced TNFR family-related gene, which are two members of the TNFR family expressed on lymphoid cells. Although Siva-1 expression is up-regulated in multiple pathological processes, little is known about the signaling pathway underlying the Siva-induced apoptosis. In this study, we investigated the mechanism of the proapoptotic activity of Siva-1 and an alternative splice form lacking the death domain of Siva-1, Siva-2, in T lymphocytes in which Siva proteins, CD27, and glucocorticoid-induced TNFR family-related gene are primarily expressed. Overexpression of Siva proteins triggers a typical apoptotic process manifested by cell shrinkage and surface exposure of phosphatidylserine, and confirmed by ultrastructural features. Siva-induced apoptosis is related to the CD27-mediated apoptotic pathway and results in activation of both initiator and effector caspases. This pathway involves a mitochondrial step evidenced by activation of Bid and cytochrome c release, and is modulated by overexpression of Bcl-2 or Bcl-xL. The determinants for Siva-induced apoptosis are not contained within the death domain found in the central part of Siva-1, but rather in both the N-terminal and C-terminal regions shared by both Siva proteins. The N-terminal region also participates in the translocation of both Siva proteins into the nuclear compartment. These results indicate that Siva-1 and Siva-2 mediate apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway that likely involves both cytoplasmic and nuclear events.
This article has been cited by other articles:
![]() |
D. L. Cottle, M. J. McGrath, B. R. Wilding, B. S. Cowling, J. M. Kane, C. E. D'Arcy, M. Holdsworth, I. Hatzinisiriou, M. Prescott, S. Brown, et al. SLIMMER (FHL1B/KyoT3) Interacts with the Proapoptotic Protein Siva-1 (CD27BP) and Delays Skeletal Myoblast Apoptosis J. Biol. Chem., September 25, 2009; 284(39): 26964 - 26977. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Resch, Y. M. Schichl, G. Winsauer, R. Gudi, K. Prasad, and R. de Martin Siva1 is a XIAP-interacting protein that balances NF{kappa}B and JNK signalling to promote apoptosis J. Cell Sci., August 1, 2009; 122(15): 2651 - 2661. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mihatsch, M. Nestler, H.-P. Saluz, A. Henke, and T. Munder Proapoptotic protein Siva binds to the muscle protein telethonin in cardiomyocytes during coxsackieviral infection Cardiovasc Res, January 1, 2009; 81(1): 108 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Ho, E. Hatjiharissi, B. T. Ciccarelli, A. R. Branagan, Z. R. Hunter, X. Leleu, O. Tournilhac, L. Xu, K. O'Connor, R. J. Manning, et al. CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia Blood, December 1, 2008; 112(12): 4683 - 4689. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-T. Lin, Y.-J. Lai, N. Makarova, G. Tigyi, and W.-C. Lin The Lysophosphatidic Acid 2 Receptor Mediates Down-regulation of Siva-1 to Promote Cell Survival J. Biol. Chem., December 28, 2007; 282(52): 37759 - 37769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fortin, J. G. MacLaurin, N. Arbour, S. P. Cregan, N. Kushwaha, S. M. Callaghan, D. S. Park, P. R. Albert, and R. S. Slack The Proapoptotic Gene SIVA Is a Direct Transcriptional Target for the Tumor Suppressors p53 and E2F1 J. Biol. Chem., July 2, 2004; 279(27): 28706 - 28714. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |